Binding and Cyclic AMP Stimulation by N-Terminally Deleted Human PTHs (3–84 and 4–84) in a Homologous Ligand Receptor System
- 1 September 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 12 (9) , 1348-1357
- https://doi.org/10.1359/jbmr.1997.12.9.1348
Abstract
We have produced in yeast two human parathyroid hormone (hPTH) analogs with amino-terminal deletions, hPTH(3-84) and hPTH(4-84), employing the mating factor alpha (MF alpha) expression system. The authenticity of the polypeptides was demonstrated by amino-terminal analysis, amino acid composition, and molecular mass analysis. In cells (LLC-PK1) transfected with the human PTH/parathyroid hormone-related protein (PTHrP) receptor, using [125I-Tyr36]chickenPTHrP(1-36)NH2 as radioligand, binding studies revealed dissociation constants at equilibrium (Kd) for hPTH(3-84) and hPTH(4-84) of 4.7 and 8.0 nM, respectively, only slightly higher than natural recombinant hPTH(1-84) Kd = 2.3 nM). In comparison, [Nle8,18,Tyr34]bovinePTH(3-34)NH2 and [Tyr36]cPTHrP(1-36)NH2 showed equal Kd's of 1.9 nM. Neither of the N-terminally deleted hPTH analogs showed any detectable stimulation of cAMP production in the cells at concentrations below 20 nM. At supersaturated concentrations (500 nM) with receptor occupancy of more than 95% these hPTH analogs revealed about 15% rest agonism compared with that of hPTH(1-84). hPTH(1-84) and [Tyr36]cPTHrP(1-36)NH2 showed an equal half maximal cyclic adenosine monophosphate (cAMP) stimulation of about 0.8 and 0.7 nM, respectively. The hPTH analogs did not show any ability to antagonize cellular cAMP production induced by either hPTH or [Tyr36]cPTHrP(1-36)NH2. [Nle8,18,Tyr34]bPTH(3-34)NH2 did also not antagonize cAMP stimulation by hPTH, but inhibited [Tyr36]cPTHrP(1-36)NH2-induced cAMP production by 40% when present at a 1000 M excess. These distinct results related to PTH and PTHrP from different species are important to consider in experiments evaluating potential hPTH or PTHrP antagonism, and employment of a hPTH/PTHrP receptor model is a requirement.Keywords
This publication has 52 references indexed in Scilit:
- The Structure Of Human Parathyroid Hormone From a Study of Fragments in Solution Using 1H NMR Spectroscopy and Its Biological ImplicationsBiochemistry, 1994
- Isolation and characterization of two biologically active O‐glycosylated forms of human parathyroid hormone produced in Saccharomyces cerevisiaeEuropean Journal of Biochemistry, 1992
- Biological activity of parathyroid hormone antagonists substituted at position 13Peptides, 1991
- Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonistsInternational Journal of Peptide and Protein Research, 1990
- Human PTH-(3–34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells)Journal of Bone and Mineral Research, 1990
- Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonistsBiochemistry, 1990
- Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1988
- Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometryAnalytical Chemistry, 1987
- Design and Synthesis of Parathyroid Hormone Analogues of Enhanced Biological ActivityEndocrine Research Communications, 1977
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970